Literature DB >> 19837489

Anti-trypanosomatid benzofuroxans and deoxygenated analogues: synthesis using polymer-supported triphenylphosphine, biological evaluation and mechanism of action studies.

Diego Castro1, Lucia Boiani, Diego Benitez, Paola Hernández, Alicia Merlino, Carmen Gil, Claudio Olea-Azar, Mercedes González, Hugo Cerecetto, Williams Porcal.   

Abstract

Hybrid vinylthio-, vinylsulfinyl-, vinylsulfonyl- and vinylketo-benzofuroxans developed as anti-trypanosomatid agents, against Trypanosoma cruzi and Leishmania spp., have showed low micromolar IC(50) values. The synthetic route to access to these derivatives was an efficient Wittig reaction performed in mild conditions with polymer-supported triphenylphosphine (PS-TPP). Additionally, the benzofurozan analogues, deoxygenated benzofuroxans, were prepared using PS-TPP as reductive reagent in excellent yields. The trypanosomicidal and leishmanocidal activities of the benzofuroxan derivatives were measured and also some aspects of their mechanism of action studied. In this sense, inhibition of mitochondrial dehydrogenases activities, production of intra-parasite free radicals and cruzipain inhibition were studied as biological target for the anti-trypanosomatid identified compounds. The trypanosomicidal activity could be the result of both the parasite-mitochondrion function interference and production of oxidative stress into the parasite.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837489     DOI: 10.1016/j.ejmech.2009.09.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Leishmanicidal activities of novel synthetic furoxan and benzofuroxan derivatives.

Authors:  Luiz Antônio Dutra; Letícia de Almeida; Thais G Passalacqua; Juliana Santana Reis; Fabio A E Torres; Isabel Martinez; Rosangela Gonçalves Peccinini; Chung Man Chin; Konstantin Chegaev; Stefano Guglielmo; Roberta Fruttero; Marcia A S Graminha; Jean Leandro dos Santos
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

2.  New hits as phase II enzymes inducers from a focused library with heteroatom-heteroatom and Michael-acceptor motives.

Authors:  Mauricio Cabrera; Stefani de Ovalle; Mariela Bollati-Fogolín; Fabiana Nascimento; Patrícia Corbelini; Fernanda Janarelli; Daniel Kawano; Vera Lucia Eifler-Lima; Mercedes González; Hugo Cerecetto
Journal:  Future Sci OA       Date:  2015-11-01

Review 3.  Polymer-supported triphenylphosphine: application in organic synthesis and organometallic reactions.

Authors:  Ziad Moussa; Zaher M A Judeh; Saleh A Ahmed
Journal:  RSC Adv       Date:  2019-11-05       Impact factor: 4.036

Review 4.  Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.

Authors:  Hugo Cerecetto; Mercedes González
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-25

5.  Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.

Authors:  Guilherme Felipe Dos Santos Fernandes; Paula Carolina de Souza; Elsa Moreno-Viguri; Mery Santivañez-Veliz; Rocio Paucar; Silvia Pérez-Silanes; Konstantin Chegaev; Stefano Guglielmo; Loretta Lazzarato; Roberta Fruttero; Chung Man Chin; Patricia Bento da Silva; Marlus Chorilli; Mariana Cristina Solcia; Camila Maríngolo Ribeiro; Caio Sander Paiva Silva; Leonardo Biancolino Marino; Priscila Longhin Bosquesi; Debbie M Hunt; Luiz Pedro S de Carvalho; Carlos Alberto de Souza Costa; Sang Hyun Cho; Yuehong Wang; Scott Gary Franzblau; Fernando Rogério Pavan; Jean Leandro Dos Santos
Journal:  J Med Chem       Date:  2017-10-16       Impact factor: 7.446

6.  Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.

Authors:  Leandro da Costa Clementino; Guilherme Felipe Santos Fernandes; Igor Muccilo Prokopczyk; Wilquer Castro Laurindo; Danyelle Toyama; Bruno Pereira Motta; Amanda Martins Baviera; Flávio Henrique-Silva; Jean Leandro Dos Santos; Marcia A S Graminha
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.